erik007tc, I do agree that currently NWBio does not have the necessary staff, personnel or sales force to fully commercialize DCVax-L.
However, I also believe it would be presumptuous, impractical, fiscally irresponsible, and foolish for NWBio to hire all these people before DCVax-L is approved by the first regulatory agency.
I believe it will take multiple regulatory approvals, and for NWBio to achieve several more major milestones before NWBO shares are fairly valued for a buyout.
Legalese boilerplate cover your ass language required by SEC regulations and laws. All easily handled with a partnership or distrubutor contract. xThe safely and effacacy of the product will take care of sales. A distributor like St Joseph, Cardinal Health, McKesson, Boots Alliance in UK or CVS will gladly sign up to handle wholesale distribution.
Well, the management said in 10K they are too busy with MAA process for them to proceed with the signing the collaboration contract with BP. Then they said prior, these collaboration will be carried out after cementing the MAA process. Doesn't this sound like arbitrary and unilateral decision by the company then cooperative with the BP's. To me LP is giving time to a potential suitor that you should better your figures for the offer made. Just a thought.
I sent a email to MHRA about CHM meeting for DCVAX and got a reply saying that the letter were rerouted to the CHM responsible person. It's been two days and no response yet. I not counting on this anymore. Maybe there will be no CHM for DCVAX, may not required and directly to approval ?
Market Data 
Markets 
AI
